Retention of new AEDs in institutionalized intellectually disabled patients with epilepsy.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Seizure

• Publication date

  2009-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.seizure.2008.07.007PMID 18760635
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacological interventions for epilepsy in people with intellectual disabilities.

  2015cited by this paper
• Lamotrigine in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.

  2008cited by this paper
• Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.

  2008cited by this paper
• Comparative retention rates and long-term tolerability of new antiepileptic drugs.

  2007cited by this paper
• Long-term retention rates of new antiepileptic drugs in adults with chronic epilepsy and learning disability.

  2007influential reference
• Efficacy and tolerability of adjunctive lamotrigine for refractory epilepsy in institutional or community residents with mental retardation*

  2006cited by this paper
• Adjunctive Lamotrigine for Refractory Epilepsy in Adolescents with Mental Retardation

  2006cited by this paper
• Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long‐term studies?

  2006cited by this paper
• New antiepileptic drugs in practice – how do they perform in the real world?

  2005cited by this paper
• Topiramate in long-term treatment of epilepsy in the intellectually disabled.

  2005cited by this paper
• The long term retention of levetiracetam in a large cohort of patients with epilepsy

  2005cited by this paper
• Levetiracetam for people with mental retardation and refractory epilepsy.

  2004cited by this paper
• Levetiracetam in adult patients with and without learning disability: focus on behavioral adverse effects.

  2004cited by this paper
• Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.

  2004cited by this paper
• Lamotrigine as adjunctive therapy in patients with refractory epilepsy and mental retardation.

  2003cited by this paper
• Limited efficacy of gabapentin in severe therapy-resistant epilepsies of learning-disabled patients.

  2003cited by this paper
• Effekte von Topiramat bei Patienten mit Epilepsie und intellektueller Beeinträchtigung

  2002cited by this paper
• Role of topiramate in adults with intractable epilepsy, mental retardation, and developmental disabilities.

  2002cited by this paper
• [Effects of topiramate in patients with epilepsy and intellectual deficits].

  2002cited by this paper
• Clinical guidelines for the management of epilepsy in adults with an intellectual disability

  2001cited by this paper
• A randomized open-label study of gabapentin and lamotrigine in adults with learning disability and resistant epilepsy.

  2001cited by this paper
• Long-term continuation of levetiracetam in patients with refractory epilepsy

  2001cited by this paper
• Prognostic Factors Affecting Long‐Term Retention of Topiramate in Patients with Chronic Epilepsy

  2000cited by this paper
• Long‐Term Retention Rates of Lamotrigine, Gabapentin, and Topiramate in Chronic Epilepsy

  2000cited by this paper
• Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation.

  2000cited by this paper
• Treatment of epilepsy in the multiply handicapped.

  2000cited by this paper
• Gabapentin in the treatment of refractory partial epilepsy in children with intellectual disability.

  1998cited by this paper
• Comprehensive Management of Epilepsy in Persons with Mental Retardation

  1997cited by this paper
• Meeting the Challenge of Epilepsy in Persons With Multiple Handicaps

  1997cited by this paper
• A naturalistic study of the use of vigabatrin, lamotrigine and gabapentin in adults with learning disabilities.

  1997cited by this paper
• The Role of the Old and the New Antiepileptic Drugs in Special Populations: Mental and Multiple Handicaps

  1996cited by this paper
• Epilepsy and mental retardation: an overview.

  1993cited by this paper
• Epilepsy in a population of mentally retarded children and adults.

  1990influential reference
• Clinical and Therapeutic Monitoring of Epilepsy in a Mental Handicap Unit

  1989influential reference

• People with intellectual disabilities and their experience of medication: A narrative literature review.

  2020cites this paper
• The role of the epilepsy monitoring unit in the investigation of patients with epilepsy and intellectual disabilities.

  2020cites this paper
• A randomized, open-label, multicenter comparative trial of levetiracetam and topiramate as adjunctive treatment for patients with focal epilepsy in Korea.

  2019cites this paper
• Efficacy and tolerability of levetiracetam for pediatric refractory epilepsy.

  2017cites this paper
• Lacosamide in the treatment of patients with epilepsy and intellectual disabilities: A long‐term study of 136 patients

  2017cites this paper
• The retention of lacosamide in patients with epilepsy and intellectual disability in three specialised institutions.

  2017cites this paper
• 53. Jahrestagung der Deutschen Gesellschaft für Epileptologie

  2016cites this paper
• Antiepileptic drug use in a nursing home setting: a retrospective study in older adults.

  2016cites this paper
• Management of Epilepsy in People with Intellectual Disabilities

  2015cites this paper
• A Practitioner’s Guide to Prescribing Lamotrigine for Adults with Intellectual Disabilities

  2012cites this paper
• A Practitioner’s Guide to Prescribing Levetiracetam for Adults with Intellectual Disabilities

  2012cites this paper
• A Practitioner’s Guide to Prescribing Gabapentin for Adults with Intellectual Disabilities

  2012cites this paper
• A comparison of antiepileptic drug therapy in patients with severe intellectual disability and patients with normal intellect.

  2012cites this paper
• A Practitioner’s Guide to Prescribing Topiramate for Adults with Intellectual Disabilities

  2012cites this paper
• Restless Legs Syndrome Tolerability of atypical neuroleptics and acetylcholinesterase inhibitors when treating neuropsychiatric symptoms in Parkinson ’ s disease

  2012cites this paper
• Tolerability of atypical neuroleptics and acetylcholinesterase inhibitors when treating neuropsychiatric symptoms in Parkinson's disease

  2012cites this paper
• 230 The Pharmacological Treatment of Patients with Epilepsy and Learning Difficulties

  2010cites this paper
• 230 The Pharmacological Treatment of Patients with Epilepsy and Learning Difficulties

  2010influential citation